selected publications
-
academic article
- Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center. Supportive Care in Cancer. 25:1063-1069. 2017
- In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients. International journal of antimicrobial agents. 49:416-421. 2017
- Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients. Diagnostic Microbiology and Infectious Disease. 87:338-342. 2017
- In Vitro activity of Ceftaroline and Comparator Agents Against Bacterial Isolates From Cancer Patients. Open Forum Infectious Diseases. 3. 2016
- In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients. Journal of Antibiotics. 69:381-387. 2016
- Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center. Infection. 43:545-550. 2015
- Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation.. Transplant Infectious Disease. 17:33-38. 2015
- Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center. American Journal of Infection Control. 42:1084–1088-1088. 2014
- In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients. The Journal of Antibiotics. 67:505-509. 2014
- Current Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective Review. Infectious Diseases and Therapy. 3:245-256. 2014
- The current spectrum of infection in cancer patients with chemotherapy related neutropenia. Infection. 42:5-13. 2014
- Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 41:1039-1040. 2013
- Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive Chemotherapy. Clinical infectious diseases. 56:711-717. 2013